EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Calcium Phosphate-Based Biomaterials for Osteogenesis and Osteosarcoma Management: Drug Delivery Strategies, Therapeutic Molecules and Challenges in Clinical Translation

Mingjie Wang, Qiang Sun, Richard T. Jaspers, Chang Du, Yuelian Liu

Journal of Functional Biomaterials · 31.10.2026 · 17 (11) · 562

DOI: 10.3390/jfb17110562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 31.10.2026. Verfasst von Mingjie Wang und 4 weiteren Autor:innen. Die Arbeit nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Research Council, GDST-NWO science industry cooperation program Chemistry, 111 Project.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is one of the most common malignant bone tumors in adolescents. Despite advances in surgical resection and systemic chemotherapy, residual microscopic disease may contribute to local recurrence, while reconstruction of post-surgical bone defects remains a significant clinical challenge. Calcium phosphate (CaP)-based biomaterials are being investigated as local delivery platforms to simultaneously provide controlled anticancer therapy and promote bone regeneration. In this review, we present a critical overview of anticancer CaP biomaterials, focusing on three key aspects: (i) the OS tumor microenvironment, which limits the efficacy of conventional chemotherapeutic treatments and impairs bone regeneration; (ii) diverse drug-loading strategies that govern drug encapsulation and release kinetics; and (iii) a broad range of therapeutic agents incorporated into CaP matrices, including chemotherapeutic drugs, phytochemicals, trace elements, and immunomodulatory agents. Despite substantial progress in this field, clinically established CaP-based platforms that achieve controlled local anticancer delivery with validated bone-regenerative performance remain limited. Therefore, we critically evaluated the major translational barriers, manufacturing challenges, and regulatory considerations that must be addressed to facilitate the clinical translation of these multifunctional biomaterials from bench to bedside.

Förderung

  • Dutch Research Council
  • GDST-NWO science industry cooperation program Chemistry
  • 111 Project

Zitieren

APA

Wang, M., Sun, Q., Jaspers, R. T., Du, C., & Liu, Y. (2026). Calcium Phosphate-Based Biomaterials for Osteogenesis and Osteosarcoma Management: Drug Delivery Strategies, Therapeutic Molecules and Challenges in Clinical Translation. Journal of Functional Biomaterials, 17(11), 562. https://doi.org/10.3390/jfb17110562

Vancouver

Wang M, Sun Q, Jaspers RT, Du C, Liu Y. Calcium Phosphate-Based Biomaterials for Osteogenesis and Osteosarcoma Management: Drug Delivery Strategies, Therapeutic Molecules and Challenges in Clinical Translation. Journal of Functional Biomaterials. 2026;17(11):562. doi:10.3390/jfb17110562

BibTeX
@article{Wang2026,
  author = {Wang, Mingjie and Sun, Qiang and Jaspers, Richard T. and Du, Chang and Liu, Yuelian},
  title = {Calcium Phosphate-Based Biomaterials for Osteogenesis and Osteosarcoma Management: Drug Delivery Strategies, Therapeutic Molecules and Challenges in Clinical Translation},
  journal = {Journal of Functional Biomaterials},
  year = {2026},
  volume = {17},
  number = {11},
  pages = {562},
  doi = {10.3390/jfb17110562}
}
Kostenlos starten →